EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease

Victoria Nankivell, Achini K Vidanapathirana, Ayla Hoogendoorn, Joanne T M Tan, Johan Verjans, Peter J Psaltis, Mark R Hutchinson, Brant C Gibson, Yiqing Lu, Ewa Goldys, Gang Zheng, Christina A Bursill iD

Cardiovascular Research · 02.07.2024 · 120 (8) · 819-838

DOI: 10.1093/cvr/cvae099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 02.05.2024. Verfasst von Victoria Nankivell und 11 weiteren Autor:innen. Beteiligte Einrichtung: Australian Research Council (ARC) Centre of Excellence for Nanoscale BioPhotonics (CNBP). Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages, Plaque, Atherosclerotic, Multifunctional Nanoparticles. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Lin Huddleston Heart Foundation Fellowship, ARC Future Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the emergence of novel diagnostic, pharmacological, interventional, and prevention strategies, atherosclerotic cardiovascular disease remains a significant cause of morbidity and mortality. Nanoparticle (NP)-based platforms encompass diverse imaging, delivery, and pharmacological properties that provide novel opportunities for refining diagnostic and therapeutic interventions for atherosclerosis at the cellular and molecular levels. Macrophages play a critical role in atherosclerosis and therefore represent an important disease-related diagnostic and therapeutic target, especially given their inherent ability for passive and active NP uptake. In this review, we discuss an array of inorganic, carbon-based, and lipid-based NPs that provide magnetic, radiographic, and fluorescent imaging capabilities for a range of highly promising research and clinical applications in atherosclerosis. We discuss the design of NPs that target a range of macrophage-related functions such as lipoprotein oxidation, cholesterol efflux, vascular inflammation, and defective efferocytosis. We also provide examples of NP systems that were developed for other pathologies such as cancer and highlight their potential for repurposing in cardiovascular disease. Finally, we discuss the current state of play and the future of theranostic NPs. Whilst this is not without its challenges, the array of multifunctional capabilities that are possible in NP design ensures they will be part of the next frontier of exciting new therapies that simultaneously improve the accuracy of plaque diagnosis and more effectively reduce atherosclerosis with limited side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMacrophagesPlaque, AtheroscleroticMultifunctional NanoparticlesHumansAnimalsNanoparticle Drug Delivery SystemTheranostic NanomedicinePredictive Value of Tests

Stichwörter der Autor:innen

AtherosclerosisMacrophagesNanoparticles

Substanzen

Nanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Australian Research Council (ARC) Centre of Excellence for Nanoscale BioPhotonics (CNBP).
  • Vascular Research Centre, Lifelong Health, South Australian Health and Medical Research Institute (SAHMRI), North Terrace, Adelaide, 5000, Australia.
  • Faculty of Health and Medical Science, The University of Adelaide, North Terrace, Adelaide, 5000, Australia.
  • School of Science, RMIT University, Melbourne, Victoria, Australia.
  • School of Engineering, Macquarie University, Sydney, NSW, Australia.
  • Graduate School of Biomedical Engineering, University of New South Wales, High Street, NSW, 2052, Australia.

ORCID-Profile: Christina A Bursill

Förderung

  • Australian Research Council
  • Lin Huddleston Heart Foundation Fellowship
  • ARC Future Fellowship

Zitieren

APA

Nankivell, V., Vidanapathirana, A. K., Hoogendoorn, A., Tan, J. T. M., Verjans, J., Psaltis, P. J., Hutchinson, M. R., Gibson, B. C., Lu, Y., Goldys, E., Zheng, G., & Bursill, C. A. (2024). Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease. Cardiovascular Research, 120(8), 819-838. https://doi.org/10.1093/cvr/cvae099

Vancouver

Nankivell V, Vidanapathirana AK, Hoogendoorn A, Tan JTM, Verjans J, Psaltis PJ, et al. Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease. Cardiovascular Research. 2024;120(8):819-838. doi:10.1093/cvr/cvae099

BibTeX
@article{Nankivell2024,
  author = {Nankivell, Victoria and Vidanapathirana, Achini K and Hoogendoorn, Ayla and Tan, Joanne T M and Verjans, Johan and Psaltis, Peter J and Hutchinson, Mark R and Gibson, Brant C and Lu, Yiqing and Goldys, Ewa and Zheng, Gang and Bursill, Christina A},
  title = {Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {8},
  pages = {819--838},
  doi = {10.1093/cvr/cvae099}
}
Kostenlos starten →